Use of medical marijuana has surged across the United States, but a new analysis finds that evidence supporting its use in treating chronic pain remains surprisingly thin. There have been few well-performed clinical trials focused on pain relief from the sort of products you’d buy at a marijuana dispensary, including smoked cannabis, edibles, extracts and… read on > read on >
U.S. veterans are at higher risk for melanoma, the deadliest form of skin cancer, than most Americans, and new research finds they are also more likely to have advanced-stage disease when it’s detected. At the time of diagnosis, “we found veterans with melanoma were more likely to present with ‘regional’ or ‘distant’ disease,” explained study… read on > read on >
Reacting to the nation’s opioid epidemic, doctors in the United States are co-prescribing fewer opioid painkillers and benzodiazepines such as Ativan and Xanax, federal health officials report. When these drugs are taken together, the odds of an overdose, even a fatal overdose, increase sharply. However, between 2016 and 2019, co-prescription of the two classes of… read on > read on >
There’s more good news for coffee lovers who already reap its other health benefits — your favorite beverage may also help protect your kidneys. “We already know that drinking coffee on a regular basis has been associated with the prevention of chronic and degenerative diseases including type 2 diabetes, cardiovascular disease and liver disease,” said… read on > read on >
Open-source automated insulin delivery (AID) systems are an effective and safe way for people with type 1 diabetes to control their blood sugar levels, researchers say. The AID systems combine an insulin pump, a continuous glucose monitor (CGM), and an algorithm that automatically adjusts insulin delivery every five minutes to keep glucose (sugar) levels in… read on > read on >
High-tech devices and communication helped ease the impact of COVID-19 lockdowns on children with type 1 diabetes, researchers said in a new study. Pandemic shutdowns caused significant disruptions in health care, and previous studies have shown that diabetes patients had worse blood sugar (glucose) control and more difficulty accessing care during the early days of… read on > read on >
Obesity is a well-known risk factor for type 2 diabetes. Now, a large new study adds to evidence that it also contributes to the much less common type 1 diabetes. The study, of nearly 1.5 million Israeli teenagers, found that those who were obese were twice as likely to develop type 1 diabetes by young… read on > read on >
Patients with advanced cancer often suffer crippling fatigue, but there has been little in the way of relief for them as they battle their disease. Now, a new investigation may have landed on a surprising solution — a dummy pill that contains no medication of any kind. “Cancer-related fatigue is the most frequent and debilitating… read on > read on >
A newly approved drug for type 2 diabetes may be a game-changer for treating obesity, too. Given as a shot once a week, tirzepatide works on two naturally occurring hormones that help tell the brain that you are full. It may be as effective as weight-loss surgery. “About nine of 10 people in the study… read on > read on >
A small study delivers startling results on the power of a new immunotherapy treatment against rectal cancer: The drug triggered remission in all the patients who got it. All of them had mismatch repair-deficient (MMRd) locally advanced rectal cancer and were given dostarlimab — an anti-PD-1 monoclonal antibody — every three weeks for six months… read on > read on >
-300x169.jpg)
